I think funds and people are souring on this as an investment. They have been waiting many years and the ceo has not distinguished himself. People can debate the results thus far but they are far from spectacular. But they may be quite good in Rett and even Parkinsons but the pathway forward is jumbled, as Doc says Rett wiill need another trial regardless, and Parkinsons has gone dark, why? Blowing smoke up your azz as an AGB-Board investor on this message board is no way to go through life. This is probably the hard truth, and expressing this on this @God Bleas Board will trigger people here. Merely because you know or think you know about something (CNS in general and ALZ in particular) as a non professional, which means you are an amateur, does not mean the area is a good investment target. Ask Doc238, who is the only professional on this board in this area of medicine. He is not invested in anavex, and he is about as good as you could ever get to give a professional assessment on this stock, and he kindly shares his posts here for retail. a magnificent song and she and Bert embody the word Spectacular, which is what it takes in this area of medicine when you are the small guy
News 
Market Data 
Discover 
